|
1
|
Garg A and Gladman D: Recognizing
psoriatic arthritis in the dermatology clinic. J Am Acad Dermatol.
63:733–748; quiz 749-750. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Queiro R, Morante I, Cabezas I and Acasuso
B: HLA-B27 and psoriatic disease: A modern view of an old
relationship. Rheumatology (Oxford). 55:221–229. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gladman DD: Psoriatic arthritis. Dermatol
Ther. 17:350–363. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rudwaleit M, van der Heijde D, Landewé R,
Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y,
et al: The Assessment of SpondyloArthritis International Society
classification criteria for peripheral spondyloarthritis and for
spondyloarthritis in general. Ann Rheum Dis. 70:25–31.
2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Helmick CG, Felson DT, Lawrence RC,
Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD,
Merkel PA, et al: National Arthritis Data Workgroup: Estimates of
the prevalence of arthritis and other rheumatic conditions in the
United States. Part I. Arthritis Rheum. 58:15–25. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Leung YY, Tam LS, Kun EW and Li EK:
Psoriatic arthritis as a distinct disease entity. J Postgrad Med.
53:63–71. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gladman DD, Antoni C, Mease P, Clegg DO
and Nash P: Psoriatic arthritis: Epidemiology, clinical features,
course, and outcome. Ann Rheum Dis. 64 (Suppl 2):ii14–ii17.
2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gladman DD, Anhorn KA, Schachter RK and
Mervart H: HLA antigens in psoriatic arthritis. J Rheumatol.
13:586–592. 1986.
|
|
9
|
Tatu AL, Elisei AM, Chioncel V, Miulescu M
and Nwabudike LC: Immunologic adverse reactions of β-blockers and
the skin. Exp Ther Med. 18:955–959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tatu AL and Nwabudike LC:
Metoprolol-associated onset of psoriatic arthropathy. Am J Ther.
24:e370–e371. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Moll JM and Wright V: Psoriatic arthritis.
Semin Arthritis Rheum. 3:55–78. 1973.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gladman DD: Axial disease in psoriatic
arthritis. Curr Rheumatol Rep. 9:455–460. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Taylor W, Gladman D, Helliwell P,
Marchesoni A, Mease P and Mielants H: CASPAR Study Group:
Classification criteria for psoriatic arthritis: Development of new
criteria from a large international study. Arthritis Rheum.
54:2665–2673. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gladman D, Ritchlin C and Sieper J:
Clinical manifestations and diagnosis of psoriatic arthritis.
UpToDate, 2018. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-psoriatic-arthritis.
|
|
15
|
Gerlag D and Tak PP: Synovial biopsy. Best
Pract Res Clin Rheumatol. 19:387–400. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gerlag DM and Tak PP: How useful are
synovial biopsies for the diagnosis of rheumatic diseases? Nat Clin
Pract Rheumatol. 3:248–249. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Saaibi DL and Schumacher HRJ Jr:
Percutaneous needle biopsy and synovial histology. Baillieres Clin
Rheumatol. 10:535–554. 1996.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Constantin MM, Nita IE, Olteanu R,
Constantin T, Bucur S, Matei C and Raducan A: Significance and
impact of dietary factors on systemic lupus erythematosus
pathogenesis (Review). Exp Ther Med. 17:1085–1090. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Raducan A, Bucur S, Caruntu C, Constantin
T, Nita IE, Manolache N and Constantin MM: Therapeutic management
with biological anti-TNF-α agent in severe psoriasis associated
with chronic hepatitis B: A case report. Exp Ther Med. 18:895–899.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Constantin MM, Cristea CM, Taranu T, Bucur
S, Constantin T, Dinu A, Jinga M and Nita IE: Biosimilars in
dermatology: The wind of change. Exp Ther Med. 18:911–915.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Raducan A, Bucur S, Caruntu C, Constantin
T, Nita IE, Manolache N and Constantin MM: Therapeutic management
with biological anti-TNF-α agent in severe psoriasis associated
with chronic hepatitis B: A case report. Exp Ther Med. 18:895–899.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Olteanu R, Zota A and Constantin M:
Biosimilars: An update on clinical trials (review of published and
ongoing studies). Acta Dermatovenerol Croat. 25:57–66.
2017.PubMed/NCBI
|
|
23
|
Gamret AC, Price A, Fertig RM, Lev-Tov H
and Nichols AJ: Complementary and alternative medicine therapies
for psoriasis: A systematic review. JAMA Dermatol. 154:1330–1337.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nwabudike LC and Tatu AL: Using
complementary and alternative medicine for the treatment of
psoriasis: A step in the right direction. JAMA Dermatol.
155(636)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nwabudike LC and Tatu A: Response to:
Murphy EC, Nussbaum D, Prussick R, Friedman AJ: Use of
complementary and alternative medicine by patients with psoriasis.
J Am Acad Dermatol. 81(e105)2019. View Article : Google Scholar
|
|
26
|
Husted JA, Tom BD, Schentag CT, Farewell
VT and Gladman DD: Occurrence and correlates of fatigue in
psoriatic arthritis. Ann Rheum Dis. 68:1553–1558. 2009.PubMed/NCBI View Article : Google Scholar
|
